JP2009526817A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009526817A5 JP2009526817A5 JP2008554769A JP2008554769A JP2009526817A5 JP 2009526817 A5 JP2009526817 A5 JP 2009526817A5 JP 2008554769 A JP2008554769 A JP 2008554769A JP 2008554769 A JP2008554769 A JP 2008554769A JP 2009526817 A5 JP2009526817 A5 JP 2009526817A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- compounds
- addition
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 150000001875 compounds Chemical class 0.000 claims 8
- 239000013543 active substance Substances 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 150000003431 steroids Chemical class 0.000 claims 5
- 239000003112 inhibitor Substances 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 2
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 claims 2
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims 2
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 2
- 230000001078 anti-cholinergic effect Effects 0.000 claims 2
- 239000000812 cholinergic antagonist Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000003380 propellant Substances 0.000 claims 2
- 208000023504 respiratory system disease Diseases 0.000 claims 2
- 230000033764 rhythmic process Effects 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- 206010003671 Atrioventricular Block Diseases 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 1
- 208000011623 Obstructive Lung disease Diseases 0.000 claims 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 claims 1
- 206010036600 Premature labour Diseases 0.000 claims 1
- 206010037423 Pulmonary oedema Diseases 0.000 claims 1
- 208000030934 Restrictive pulmonary disease Diseases 0.000 claims 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 230000003288 anthiarrhythmic effect Effects 0.000 claims 1
- 239000003416 antiarrhythmic agent Substances 0.000 claims 1
- 230000000059 bradycardiac effect Effects 0.000 claims 1
- 201000009267 bronchiectasis Diseases 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 230000005796 circulatory shock Effects 0.000 claims 1
- 230000001054 cortical effect Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 229940121647 egfr inhibitor Drugs 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 230000000414 obstructive effect Effects 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 208000026440 premature labor Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 208000005333 pulmonary edema Diseases 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 230000024883 vasodilation Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06110009 | 2006-02-16 | ||
| PCT/EP2007/051408 WO2007093608A1 (de) | 2006-02-16 | 2007-02-14 | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009526817A JP2009526817A (ja) | 2009-07-23 |
| JP2009526817A5 true JP2009526817A5 (https=) | 2010-04-02 |
Family
ID=35983924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008554769A Pending JP2009526817A (ja) | 2006-02-16 | 2007-02-14 | 呼吸器疾患の治療用医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20070203125A1 (https=) |
| EP (1) | EP1986644A1 (https=) |
| JP (1) | JP2009526817A (https=) |
| AR (1) | AR059533A1 (https=) |
| CA (1) | CA2642239A1 (https=) |
| TW (1) | TW200803848A (https=) |
| WO (1) | WO2007093608A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20080142A1 (es) * | 2006-03-15 | 2008-04-14 | Boehringer Ingelheim Int | Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion |
| CN110003025A (zh) * | 2019-04-29 | 2019-07-12 | 天津华津制药有限公司 | 1-[2-羟基-3-氨基-5-(苄氧基)苯基]-乙酮的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2609645A1 (de) * | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
| DE2833140A1 (de) * | 1978-07-28 | 1980-02-07 | Boehringer Sohn Ingelheim | Neue n-substituierte heterocyclen |
| US6790856B2 (en) * | 2002-01-31 | 2004-09-14 | Boehringer Ingelheim Pharma Kg | Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
| US7368435B2 (en) * | 2002-09-12 | 2008-05-06 | Summit Vetpharm, Llc | Topical endoparasiticide and ectoparasiticide formulations |
| DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| DE102004019540A1 (de) * | 2004-04-22 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen |
| EP1577306A1 (de) * | 2004-03-17 | 2005-09-21 | Boehringer Ingelheim Pharma GmbH & Co.KG | Neue Benzoxazinonderivate als langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen |
| US7244728B2 (en) * | 2004-03-17 | 2007-07-17 | Boehringer Ingelheim International Gmbh | Long acting betamimetics for the treatment of respiratory diseases |
| US20050239778A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Novel medicament combinations for the treatment of respiratory diseases |
| AU2005235419B2 (en) * | 2004-04-22 | 2010-11-04 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations containing benzoxazine for treating respiratory diseases |
| DE102004024454A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| DE102004045648A1 (de) * | 2004-09-21 | 2006-03-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Betamimetika zur Behandlung von Atemwegserkrankungen |
-
2007
- 2007-02-14 WO PCT/EP2007/051408 patent/WO2007093608A1/de not_active Ceased
- 2007-02-14 EP EP07726364A patent/EP1986644A1/de not_active Withdrawn
- 2007-02-14 CA CA002642239A patent/CA2642239A1/en not_active Abandoned
- 2007-02-14 JP JP2008554769A patent/JP2009526817A/ja active Pending
- 2007-02-15 TW TW096105758A patent/TW200803848A/zh unknown
- 2007-02-16 AR ARP070100672A patent/AR059533A1/es not_active Application Discontinuation
- 2007-02-16 US US11/675,932 patent/US20070203125A1/en not_active Abandoned
-
2010
- 2010-08-02 US US12/848,364 patent/US20100297028A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI272106B (en) | New medicament compositions based on anticholinergically-effective compounds and beta-mimetics | |
| ES2892954T3 (es) | Derivados fluorados del ácido 3-(2-oxo-3-(3-(5,6,7,8-tetrahidro-1,8-naftiridin-2-il)propil)imidazolidin-1-il)propanoico y usos de los mismos | |
| CN102946868B (zh) | 包含抗毒蕈碱药的干粉制剂 | |
| RU2004126441A (ru) | Новые антихолинергические средства, способ их получения, а также их применение в качестве лекарственных средств | |
| MX2007013766A (es) | Combinacion de inhibidor pde4 de roflumilast y un derivado de tetrahidrobiopterina. | |
| JP2005525323A5 (https=) | ||
| JP2004521134A5 (https=) | ||
| JP2005516067A5 (https=) | ||
| US20040002548A1 (en) | Medicament compositions containing anticholinergically-effective compounds and betamimetics | |
| RU2010108640A (ru) | Новая комбинация терапевтических агентов | |
| JP2010516702A5 (https=) | ||
| JP2011524896A5 (https=) | ||
| JP5081158B2 (ja) | 呼吸器系疾患治療用の新規な医薬組成物 | |
| KR20240144178A (ko) | 심폐 장애의 치료 | |
| JP2007500676A5 (https=) | ||
| JP2009526817A5 (https=) | ||
| JP5468543B2 (ja) | アセトアミド立体異性体 | |
| JP2009532413A5 (https=) | ||
| CN112076180B (zh) | 抗高血压的多元醇化合物及其衍生物 | |
| JP6787926B2 (ja) | 肺高血圧症の治療方法 | |
| JP2007524699A (ja) | ロフルミラストとグリコピロニウムとの組合せ物 | |
| JP2007524699A5 (https=) | ||
| TWI555528B (zh) | 泛醇基二十二碳六烯酸酯及其於治療與預防心血管疾病的用途 | |
| JP2005529110A5 (https=) | ||
| JP2008528547A5 (https=) |